Advertisement

Topics

InDex initiates enrolment for Phase IIb trial of cobitolimod to treat ulcerative colitis

19:00 EDT 21 Jun 2017 | Net Resources International

Sweden-based InDex Pharmaceuticals has started patient enrolment in Phase IIb CONDUCT clinical trial of cobitolimod for treatment of patients with ulcerative colitis.

Original Article: InDex initiates enrolment for Phase IIb trial of cobitolimod to treat ulcerative colitis

NEXT ARTICLE

More From BioPortfolio on "InDex initiates enrolment for Phase IIb trial of cobitolimod to treat ulcerative colitis"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...